System and method for delivery of energy to tissue while compensating for collateral tissue

• US 8,414,508 B2
• Filed: 10/30/2009
• Issued: 04/09/2013
• Est. Priority Date: 10/30/2008
• Status: Active Grant

• Current Assignee: Auris Health, Inc. (Johnson & Johnson)
• Original Assignee: VytronUS, Inc. (Johnson & Johnson)
• Inventors: Thapliyal, Hira V., Gallup, David A., Arenson, James W.
• Primary Examiner(s): MEHTA, PARIKHA SOLANKI
• Application Number:
  US12/609,274
• Publication Number:
  US 20100113928A1
• Time in Patent Office: 1,257 Days
• Field of Search: 600/407, 600/411, 600/412, 600/427, 600/438, 600/439, 600/474, 600/508, 600/549, 601/2, 604/22, 606 27- 40, 607/2, 607 96-102, 607115-132
• US Class Current: 601/2
• CPC Class Codes: A61B 2017/00106 ultrasonic
• CPC Class Codes: A61B 2017/00243 cardiac
• CPC Class Codes: A61B 2018/00005 Cooling or heating of the probe or tissue immediately surrounding the probe
• CPC Class Codes: A61B 5/0008 Temperature signals
• CPC Class Codes: A61B 5/4893 Nerves
• CPC Class Codes: A61B 8/08 Detecting organic movements or changes, e.g. tumours, cysts, swellings A61B8/02 - A61B8/06 take precedence
• CPC Class Codes: A61B 90/98 using electromagnetic means, e.g. transponders
• CPC Class Codes: A61N 2007/0026 Stimulation of nerve tissue
• CPC Class Codes: A61N 2007/0078 with multiple treatment transducers
• CPC Class Codes: A61N 7/022 intracavitary

Abstract

A tissue ablation method for treating atrial fibrillation in a patient comprises locating an ostium of a pulmonary vein and positioning an interventional catheter adjacent the ostium. The interventional catheter has an energy source. Collateral tissue adjacent the ostium is located and tissue around the ostium is ablated with energy from the energy source so as to form a contiguous lesion circumscribing the ostium. The lesion blocks aberrant electrical pathways in the tissue so as to reduce or eliminate the atrial fibrillation. The ablating is modified so as to avoid ablating or otherwise damaging the collateral tissue.

Claims

1. A tissue ablation method for treating atrial fibrillation in a patient, said method comprising:

locating an ostium of a pulmonary vein;

positioning an interventional catheter adjacent the ostium, the interventional catheter having an energy source;

identifying collateral tissue adjacent the ostium;

ablating tissue around the ostium with energy from the energy source so as to form a contiguous lesion circumscribing the ostium, the lesion blocking aberrant electrical pathways in the tissue so as to reduce or eliminate the atrial fibrillation; and

modifying the ablating so as to avoid ablating or otherwise damaging the collateral tissue, wherein modifying comprises changing the continuous lesion circumscribing the ostium to a new lesion path that continuously circumscribes the ostium.

2. The method of claim 1, wherein the interventional catheter further comprises a sensor adjacent the energy source, and wherein the locating step comprises delivering energy from the energy source toward the tissue adjacent the ostium, and sensing energy reflected from the tissue adjacent the ostium with the sensor.

3. The method of claim 2, wherein the sensor comprises at least a portion of the energy source.

4. The method of claim 1, wherein the positioning comprises intravascularly advancing the interventional catheter into a left atrium of the patient'"'"'s heart.

5. The method of claim 1, wherein the identifying comprises characterizing properties of the tissue adjacent the ostium and comparing the properties with known tissue properties.

6. The method of claim 1, wherein the identifying comprises a diagnostic sweep of tissue adjacent the ostium, the sweep being a systematic scan to acquire information about the tissue adjacent the ostium.

7. The method of claim 1, wherein the identifying is performed while the ablating is being performed.

8. The method of claim 1, wherein the modifying comprises modifying the lesion so as to avoid the collateral tissue.

9. The method of claim 1, wherein the modifying comprises changing the energy emitted from the energy source so as to avoid damaging the collateral tissue.

10. The method of claim 1, wherein the collateral tissue comprises an esophagus.

11. The method of claim 10, wherein the identifying comprises positioning an esophageal detection device into the esophagus.

12. The method of claim 11, wherein the identifying comprises sensing the presence of the detection device through one or more layers of tissue.

13. The method of claim 11, wherein the esophageal detection device comprises a balloon catheter.

14. The method of claim 13, wherein the balloon catheter is filled with a fluid, the method further comprising sensing the fluid in the balloon catheter with an ultrasound signal delivered by the energy source.

15. The method of claim 14, wherein the fluid is one of saline, water, air, and carbon dioxide.

16. The method of claim 11, wherein the esophageal detection device comprises a transponder.

17. The method of claim 16, wherein the transponder comprises one of a reflective material, a chemical substance, RFID tag, a capacitive plate, an inductive component, an ultrasound transducer, and an infrared light.

18. The method of claim 11, wherein the esophageal detection device further protects the esophagus by cooling the esophagus.

19. The method of claim 11, wherein the identifying comprises sensing the esophageal detection device with the interventional catheter.

20. A tissue ablation system for treating atrial fibrillation in a patient, said system comprising:

an interventional catheter having an energy source and a sensor, wherein the energy source is adapted to deliver a beam of energy to tissue thereby ablating tissue around an ostium of a pulmonary vein to form a contiguous lesion circumscribing the ostium, the lesion blocking aberrant electrical pathways in the tissue so as to reduce or eliminate the atrial fibrillation; and

an esophageal detection device positionable in the esophagus, the detection device having a transponder detectable by the sensor through one or more layers of tissue, and

wherein the sensor provides feedback to the interventional catheter based on the detection of the esophageal detection device so as to modify the continuous lesion circumscribing the ostium to a new lesion path that continuously circumscribes the ostium.

21. The system of claim 20, wherein the detection device comprises a balloon catheter.

22. The system of claim 21, wherein the balloon catheter is at least partially filled with a fluid, and wherein the beam of energy comprises an ultrasound signal that reflects off the fluid filled portion of the balloon catheter and is sensed by the sensor.

23. The system of claim 22, wherein the fluid is one of saline, water, air, and carbon dioxide.

24. The system of claim 20, wherein the transponder comprises one of a reflective material, a chemical substance, RFID tag, a capacitive plate, an inductive component, an ultrasound transducer, and an infrared light.

25. The system of claim 20, wherein the energy source comprises an ultrasound transducer.

26. The system of claim 25, wherein the sensor comprises at least a portion of the ultrasound transducer.